Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D07GLX
|
||||
| Former ID |
DIB013170
|
||||
| Drug Name |
CNS-1531
|
||||
| Indication | Neuropathy [ICD9: 356.0, 356.8; ICD10:G64, G90.0] | Terminated | [1] | ||
| Company |
CeNeS Pharmaceuticals Inc
|
||||
| Structure |
|
Download2D MOL |
|||
| Canonical SMILES |
C12c3c(CC(NC2)c2c1cccc2)ccc(c3)F
|
||||
| Target and Pathway | |||||
| Target(s) | NMDA receptor | Target Info | Modulator | [2] | |
| References | |||||
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800001975) | ||||
| REF 2 | WO patent application no. 2009,0164,86, Use of nmda receptor antagonists for treatment of urologic tumors. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.